
VIC, a US-based venture development firm, forms and supports new tech companies for commercializing licensed technologies.
victech.comCrawled Oct 16, 2026
Ajay Gupta is Senior Partner Emeritus at McKinsey & Company and has 30 years of global experience across multiple healthcare segments. He serves on several healthcare and advisory boards, including the Shirley Ryan Ability Lab Keystone Board and the RAND Health Advisory Board.
Amir Baluch, MD, is an investor, serial entrepreneur, and fund manager at BioWise Capital, LLC. He has six years of experience in private equity and securities and four years of experience at a broker-dealer.
Arlen Meyers, MD, is President and CEO of the Society of Physician Entrepreneurs and has created medical device and digital health companies. He consults and speaks internationally on bio entrepreneurship, bioscience, healthcare, and healthcare IT.
Bernie Prusaczyk is a VIC Strategic Advisory Board member and former Managing Director of VIC Massachusetts Branch. He is an executive with more than 25 years of leadership experience, including in medical devices and business intelligence.
VIC selects technologies for commercial opportunities and societal impact, then forms companies to commercialize them. Its portfolio is managed by business executives and funded through the VIC Investor Network and other co-investors.
VIC Technology Venture Development lists its headquarters phone number as 479-571-2592.
VIC creates and develops life science companies based on technologies exclusively licensed from research institutions worldwide.
VIC Technology Venture Development's privacy notice was last updated October 1, 2021. The company says it is committed to protecting personal information and privacy.